Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Shanghai Mild Cognitive Impairment Cohort Study

This study is ongoing, but not recruiting participants.
Fudan University
Information provided by (Responsible Party):
Translational Research Informatics Center, Kobe, Hyogo, Japan Identifier:
First received: February 15, 2012
Last updated: September 17, 2015
Last verified: September 2015
This study was planned 1) to identify individuals with Mild Cognitive Impairment (MCI) who convert to Alzheimer's Disease (AD), and 2) to explore factors associated with the conversion.

Mild Cognitive Impairment

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Shanghai Cohort Study on Mild Cognitive Impairment for Early Detection of Alzheimer's Disease

Resource links provided by NLM:

Further study details as provided by Translational Research Informatics Center, Kobe, Hyogo, Japan:

Primary Outcome Measures:
  • Time to Conversion from MCI to "Probable AD Dementia" [ Time Frame: 3 years ]

Secondary Outcome Measures:
  • Time to Conversion from MCI to "Possible AD Dementia" or "Probable AD Dementia" [ Time Frame: 3 years ]
  • Time to Conversion from MCI to "All-cause Dementia" [ Time Frame: 3 years ]
  • Overall survival [ Time Frame: 3 years ]
  • Changes in Neuropsychological examinations [ Time Frame: baseline, annual and 3 years ]
  • Changes in MRI [ Time Frame: baseline, annual and 3 years ]

Enrollment: 400
Study Start Date: February 2012
Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)
single-group MCI patients


Ages Eligible for Study:   up to 90 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Inclusion Criteria:

  1. Cognitive concern reflecting a change in cognition reported by the patient or informant or clinician
  2. Mini-Mental State Examination (MMSE) scores between 18-30 (inclusive)
  3. Clinical Dementia Rating (CDR) =0.5; Memory Box score must be at least 0.5
  4. Objective memory loss* as evidenced by Auditory Verbal Learning test (AVLT-HS)
  5. Essentially preserved activities of daily living based on Alzheimer's Disease Cooperative Study - Activities of Daily Living (ADCS-ADL)
  6. Not-demented, as defined by '"All-cause Dementia" (see 3.4. All-cause Dementia)
  7. Willing to and able to undergo all test procedures including neuroimaging, and agree to longitudinal follow up
  8. Written informed consent for the participation of this study including repeated neuropsychological tests and MRI scans
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01552265

China, Shanghai
Department of Neurology, Huashan Hospital, Fudan University
Shanghai, Shanghai, China, 200040
Sponsors and Collaborators
Translational Research Informatics Center, Kobe, Hyogo, Japan
Fudan University
Study Director: Yoji Nagai, MD,PhD Translational Research Informatics Center, Foundation for Biomedical Research and Innovation, Kobe,Japan
  More Information

Additional Information:
Responsible Party: Translational Research Informatics Center, Kobe, Hyogo, Japan Identifier: NCT01552265     History of Changes
Other Study ID Numbers: TRIAD1109
Study First Received: February 15, 2012
Last Updated: September 17, 2015

Keywords provided by Translational Research Informatics Center, Kobe, Hyogo, Japan:
Mild Cognitive Impairment
Alzheimer's Disease

Additional relevant MeSH terms:
Alzheimer Disease
Cognition Disorders
Mild Cognitive Impairment
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders processed this record on April 25, 2017